Harlan Krumholz

How To Disseminate Complete Clinical Trial Data

5 Comments

By Ed Silverman // October 14th, 2011 // 8:33 am

Avandia: Lessons Learned & Unanswered Questions

7 Comments

By Ed Silverman // September 24th, 2010 // 8:51 am

Pharmalot… Pharmalittle… The Weekend Nears

6 Comments

By Ed Silverman // July 23rd, 2010 // 6:52 am

Avandia: One Drug, But So Many Opinions

1 Comment

By Ed Silverman // April 29th, 2010 // 7:52 am

‘Let My Pharmalot Go!’

23 Comments

By Ed Silverman // March 29th, 2010 // 3:32 pm

Pharma, Conflicts Of Interest And Fingerpointers

34 Comments

By Ed Silverman // December 15th, 2009 // 9:32 am

Vioxx Risks Could Have Been Detected In 2000

3 Comments

By Ed Silverman // November 23rd, 2009 // 7:10 pm

The Vytorin Anomaly: ‘You’ve Got To Be Worried’

25 Comments

By Ed Silverman // July 26th, 2008 // 8:35 am

FDA Will Take A ‘Balanced’ View Of Enhance: Analyst

10 Comments

By Ed Silverman // April 4th, 2008 // 12:21 pm

The Vytorin Saga Continues: Krumholz Strikes Back

8 Comments

By Ed Silverman // April 3rd, 2008 // 7:09 am

Older posts »

Clear

Clear

All rights reserved, UBM Canon. Copyright, UBM Canon.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/